O'Connor Acciani & Levy
N/aCopyright © 2023 O'Connor, Acciani and Levy. All rights reserved.
Please be advised that O’Connor, Acciani & Levy are no longer accepting cases for Limbrel.
If you took the osteoarthritis medication Limbrel and suffered life-threatening health issues like hypersensitivity pneumonitis or drug-induced liver injury, you may be entitled to compensation for damages caused by your injuries.
Contact the defective drug attorneys at O’Connor, Acciani & Levy for a free legal consultation to review your options. We are currently investigating claims for patients who were injured while taking this medication. The manufacturer, Primus Pharmaceuticals, could be held liable if you began taking this medication before the U.S. Food and Drug Administration (FDA) asked it to immediately recall the drug in Nov. 2017.
When you meet with our skilled Cincinnati Limbrel lawyers, there is no obligation to pursue a case and we do not get paid unless we recover compensation.
The drug Limbrel has been marketed as a medical food that can help patients manage the dietary and metabolic processes associated with osteoarthritis. This is a medical condition that causes cartilage in the joints to break down, resulting in stiffness, swelling and pain.
According to Primus Pharmaceuticals, Limbrel is designed to restore a patient’s metabolic balance to help reduce inflammation.
However, the FDA has received numerous reports of severe injuries from this drug, including hypersensitivity pneumonitis and drug-induced liver disease.
This refers to pulmonary disorders that can cause inflammation of the alveoli in patients’ lungs when they inhale organic dust particles. This condition is sometimes referred to as allergic alveolitis or extrinsic allergic alveolitis.
Some of the most common symptoms of this medical condition include:
Seek medical attention immediately if you took Limbrel and are experiencing any of these side effects.
Another problem with Limbrel is that it may damage your liver, either from the outside or by transforming into a toxic substance once inside this organ. This is known as drug-induced liver disease- and it has been associated with prescription medications like Limbrel, along with over-the-counter medications, vitamins, hormones, herbs or illegal drugs.
If you experience any of the following symptoms, you may have drug-induced liver disease and should seek medical treatment right away:
Drug-induced liver disease and hypersensitivity pneumonitis could be life-threatening and will likely result in expensive medical bills, along with physical pain and suffering and various other damages. Patients suffering these issues should contact a trusted Cincinnati attorney to find out if they can file a Limbrel lawsuit to obtain compensation for these expenses.
In September 2017, the FDA started to investigate the increase in reports of serious adverse events caused by Limbrel, including drug-induced liver disease and hypersensitivity pneumonitis.
The FDA had received almost 200 adverse reports by early November of that year. The organization decided this was enough evidence to link Limbrel to these severe side effects and released a public advisory on Nov. 21, 2017. The FDA advisory told Limbrel patients to immediately stop taking the drug because of the risk of severe, possibly life-threatening medical problems.
Just nine days later, on Nov. 30, 2017, the FDA requested that the manufacturer voluntarily recall Limbrel. The company chose not to do a recall so the FDA made a formal request for a recall on Dec. 18, 2017.
The FDA requested that Primus recall and immediately cease distributing the following Limbrel products:
The FDA has recommended a Class I recall of Limbrel, which means the drug is a serious health hazard that could endanger patients’ lives.
The FDA’s formal recall request stated that the recalled Limbrel products were unapproved new drugs that had been distributed in violation of two sections of the Federal Food, Drug, and Cosmetic Act. The FDA communication noted that these products met the definition of new drugs under section 201(g)(1)(B) because they were intended to cure, mitigate, treat or prevent disease.
However, the FDA said Primus made misleading and false claims that Limbrel was a medical food meant to help patients manage symptoms of osteoarthritis. The FDA communication said Limbrel products do not fit the definition of medical foods under the Orphan Drug Act (21 U.S.C. § 360ee(b)(3)), which says these products are meant to be used under doctor supervision to help with specific dietary needs and nutrition requirements of certain diseases or medical conditions.
Limbrel cannot be classified as a medical food because there are no distinctive nutritional requirements for people diagnosed with osteoarthritis, according to the FDA.
Primus Pharmaceuticals’ false and misleading claims about Limbrel mean that it could be held liable for injuries patients suffered while taking this medication. Drug manufacturers have a legal obligation to produce safe medications and advertise them correctly so patients and their doctors know the risks.
The Cincinnati attorneys at our firm can review your situation and determine if you can file a Limbrel lawsuit.
Our attorneys are currently investigating claims by those who suffered severe side effects while taking Limbrel. We are prepared to launch a comprehensive investigation of your situation to determine if you are owed compensation for medical expenses and other damages. Our Cincinnati Limbrel lawyers can manage every aspect of the complicated legal process to pursue the justice and compensation you deserve.
We offer all of our clients a free, no obligation legal consultation and will not charge for our services unless we recover compensation for you.
O'Connor Acciani & Levy
N/aCopyright © 2023 O'Connor, Acciani and Levy. All rights reserved.